Resumes
Resumes
Pei Jin Phones & Addresses
-
Modesto, CA
-
101 Rue Monet, Foothill Ranch, CA 92610 (949) 588-9428
-
Lake Forest, CA
-
San Francisco, CA
Publications
Us Patents
Cd40-Related Receptor That Binds Cd40L
View pageUS Patent:
7378492, May 27, 2008
Filed:
Feb 18, 2003
Appl. No.:
10/504973
Inventors:
Narinder K. Chawla - Union City CA, US
Henry Yue - Sunnyvale CA, US
Thomas W. Richardson - Redwood City CA, US
Joseph P. Marquis - San Jose CA, US
Ann E. Gorvad - Livermore CA, US
Shanya D. Becha - Castro Valley CA, US
Amy E. Kable - San Francisco CA, US
Anita Swarnakar - San Francisco CA, US
Pei Jin - Palo Alto CA, US
Phillip R. Hawkins - Mountain View CA, US
David Chien - Los Altos CA, US
Jayalaxmi Ramkumar - Freemont CA, US
Uyen K. Tran - San Jose CA, US
April J. A. Hafalia - Santa Clara CA, US
Mariah R. Baughn - San Leandro CA, US
Soo Yeun Lee - Daly City CA, US
Xin Jiang - Saratoga CA, US
Alan A. Jackson - Los Gatos CA, US
Reena Khare - Saratoga CA, US
Sean A. Bulloch - Cupertino CA, US
Henry Yue - Sunnyvale CA, US
Thomas W. Richardson - Redwood City CA, US
Joseph P. Marquis - San Jose CA, US
Ann E. Gorvad - Livermore CA, US
Shanya D. Becha - Castro Valley CA, US
Amy E. Kable - San Francisco CA, US
Anita Swarnakar - San Francisco CA, US
Pei Jin - Palo Alto CA, US
Phillip R. Hawkins - Mountain View CA, US
David Chien - Los Altos CA, US
Jayalaxmi Ramkumar - Freemont CA, US
Uyen K. Tran - San Jose CA, US
April J. A. Hafalia - Santa Clara CA, US
Mariah R. Baughn - San Leandro CA, US
Soo Yeun Lee - Daly City CA, US
Xin Jiang - Saratoga CA, US
Alan A. Jackson - Los Gatos CA, US
Reena Khare - Saratoga CA, US
Sean A. Bulloch - Cupertino CA, US
Assignee:
Incyte Corporation - Wilmington DE
International Classification:
C07K 14/705
C07K 19/00
C07K 19/00
US Classification:
530350, 435 691, 435 697, 536 234, 536 235
Abstract:
Various embodiments of the invention provide human receptors and membrane-associated proteins (REMAP) and Q polynucleotides which identify and encode REMAP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of REMAP.
G-Protein Coupled Receptors
View pageUS Patent:
20040152157, Aug 5, 2004
Filed:
Oct 27, 2003
Appl. No.:
10/476204
Inventors:
Michael Thornton - Oakland CA, US
Narinder Chawla - Union City CA, US
Kimberly Gietzen - San Jose CA, US
Anita Swarnakar - San Francisco CA, US
Mariah Baughn - Los Angeles CA, US
Bridget Warren - San Marcos CA, US
Jayalaxmi Ramkumar - Fremont CA, US
Monique Yao - Mountain View CA, US
Pei Jin - Palo Alto CA, US
Deborah Kallick - Galveston TX, US
Thomas Richardson - Redwood City CA, US
Mark Borowsky - Needham MA, US
Richard Graul - San Francisco CA, US
Junming Yang - San Jose CA, US
Li Ding - Creve Coeur MO, US
Glenn Fu - Dublin CA, US
Narinder Chawla - Union City CA, US
Kimberly Gietzen - San Jose CA, US
Anita Swarnakar - San Francisco CA, US
Mariah Baughn - Los Angeles CA, US
Bridget Warren - San Marcos CA, US
Jayalaxmi Ramkumar - Fremont CA, US
Monique Yao - Mountain View CA, US
Pei Jin - Palo Alto CA, US
Deborah Kallick - Galveston TX, US
Thomas Richardson - Redwood City CA, US
Mark Borowsky - Needham MA, US
Richard Graul - San Francisco CA, US
Junming Yang - San Jose CA, US
Li Ding - Creve Coeur MO, US
Glenn Fu - Dublin CA, US
International Classification:
C07K014/705
C07H021/04
C07H021/04
US Classification:
435/069100, 530/350000, 435/320100, 435/325000, 536/023500
Abstract:
The invention provides human G-protein coupled receptors (GCREC) and polynucleotides which identify and encode GCREC. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of GCREC.
Neurotransmisson-Associated Proteins
View pageUS Patent:
20040203014, Oct 14, 2004
Filed:
Mar 12, 2004
Appl. No.:
10/489372
Inventors:
Cynthia Honchell - San Francisco CA, US
Bridget Warren - San Marcos CA, US
Mark Borowsky - Needham MA, US
Jennifer Griffin - Fremont CA, US
Joana Li - Millbrae CA, US
Soo Lee - Mountain View CA, US
Henry Yue - Sunnyvale CA, US
Ian Forsythe - Edmonton, CA
Joseph Marquis - San Jose CA, US
Kimberly Gietzen - San Jose CA, US
Mariah Baughn - Los Angeles CA, US
Uyen Tran - San Jose CA, US
Y. Tang - San Jose CA, US
Jayalaxmi Ramkumar - Fremont CA, US
Brooke Emerling - Chicago IL, US
Ernestine Lee - Kensington CA, US
Vicki Elliott - San Jose CA, US
April Hafalia - Daly City CA, US
Brendan Duggan - Sunnyvale CA, US
Narinder Chawla - Union City CA, US
Amy Kable - Silver Spring MD, US
Hsin-Ru Chang - Belmont CA, US
Reena Khare - Saratoga CA, US
Shanya Becha - San Francisco CA, US
Pei Jin - Palo Alto CA, US
Sally Lee - San Jose CA, US
Bridget Warren - San Marcos CA, US
Mark Borowsky - Needham MA, US
Jennifer Griffin - Fremont CA, US
Joana Li - Millbrae CA, US
Soo Lee - Mountain View CA, US
Henry Yue - Sunnyvale CA, US
Ian Forsythe - Edmonton, CA
Joseph Marquis - San Jose CA, US
Kimberly Gietzen - San Jose CA, US
Mariah Baughn - Los Angeles CA, US
Uyen Tran - San Jose CA, US
Y. Tang - San Jose CA, US
Jayalaxmi Ramkumar - Fremont CA, US
Brooke Emerling - Chicago IL, US
Ernestine Lee - Kensington CA, US
Vicki Elliott - San Jose CA, US
April Hafalia - Daly City CA, US
Brendan Duggan - Sunnyvale CA, US
Narinder Chawla - Union City CA, US
Amy Kable - Silver Spring MD, US
Hsin-Ru Chang - Belmont CA, US
Reena Khare - Saratoga CA, US
Shanya Becha - San Francisco CA, US
Pei Jin - Palo Alto CA, US
Sally Lee - San Jose CA, US
International Classification:
C12Q001/68
C07H021/04
C12N015/00
C07K014/705
C07H021/04
C12N015/00
C07K014/705
US Classification:
435/006000, 435/069100, 435/320100, 435/325000, 530/350000, 536/023500
Abstract:
Various embodiments of the invention provide human neurotransmission-associated proteins (NTRAN) and polynucleotides which identify and encode NTRAN. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of NTRAN.
Enzymes
View pageUS Patent:
20050118594, Jun 2, 2005
Filed:
Dec 12, 2002
Appl. No.:
10/498788
Inventors:
Narinder Chawla - Union City CA, US
Soo Lee - Daly City CA, US
Huijun Ring - Los Altos CA, US
Ernestine Lee - Castro Valley CA, US
Ian Forsythe - Redwood City CA, US
Reena Khare - Saratoga CA, US
Uyen Tran - San Jose CA, US
Amy Kable - San Francisco CA, US
Thomas Richardson - Redwood City CA, US
Brooke Emerling - Palo Alto CA, US
Erika Lindquist - Alameda CA, US
Mariah Baughn - San Leandro CA, US
April Hafalia - Santa Clara CA, US
Pei Jin - Palo Alto CA, US
Anita Swarnakar - San Francisco CA, US
Joana Li - San Francisco CA, US
Joseph Marquis - San Jose CA, US
Ann Gorvad - Livermore CA, US
William Sprague - Sacramento CA, US
Shanya Becha - Castro Valley CA, US
Vicki Elliott - San Jose CA, US
Soo Lee - Daly City CA, US
Huijun Ring - Los Altos CA, US
Ernestine Lee - Castro Valley CA, US
Ian Forsythe - Redwood City CA, US
Reena Khare - Saratoga CA, US
Uyen Tran - San Jose CA, US
Amy Kable - San Francisco CA, US
Thomas Richardson - Redwood City CA, US
Brooke Emerling - Palo Alto CA, US
Erika Lindquist - Alameda CA, US
Mariah Baughn - San Leandro CA, US
April Hafalia - Santa Clara CA, US
Pei Jin - Palo Alto CA, US
Anita Swarnakar - San Francisco CA, US
Joana Li - San Francisco CA, US
Joseph Marquis - San Jose CA, US
Ann Gorvad - Livermore CA, US
William Sprague - Sacramento CA, US
Shanya Becha - Castro Valley CA, US
Vicki Elliott - San Jose CA, US
International Classification:
C12Q001/68
G01N033/53
C07H021/04
C12N009/00
G01N033/53
C07H021/04
C12N009/00
US Classification:
435006000, 435007100, 435069100, 435320100, 435325000, 435183000, 530388260, 536023200
Abstract:
Various embodiments of the invention provide human enzymes (ENZM) and polynucleotides which identify and encode-ENZM. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of ENZM.
Intron Fusion Proteins, And Methods Of Identifying And Using Same
View pageUS Patent:
20050239088, Oct 27, 2005
Filed:
May 14, 2004
Appl. No.:
10/846113
Inventors:
H. Shepard - San Francisco CA, US
Gail Clinton - Portland OR, US
David Lackey - San Diego CA, US
Pei Jin - Palo Alto CA, US
Gail Clinton - Portland OR, US
David Lackey - San Diego CA, US
Pei Jin - Palo Alto CA, US
International Classification:
C12Q001/68
C07H021/04
C12N009/12
C12N015/09
C07H021/04
C12N009/12
C12N015/09
US Classification:
435006000, 435069100, 435194000, 435320100, 435325000, 536023200
Abstract:
Isoforms of receptor tyrosine kinases, including intron fusion proteins and pharmaceutical compositions containing receptor tyrosine kinase isoforms, including intron fusion proteins, are provided herein. Methods of identifying and preparing isoforms of cell surface receptors including receptor tyrosine kinases are provided. Also provided are methods of treatment with cell surface receptor isoforms including intron fusion proteins of receptor tyrosine kinases.
Cell Surface Receptor Isoforms And Methods Of Identifying And Using The Same
View pageUS Patent:
20060286102, Dec 21, 2006
Filed:
May 13, 2005
Appl. No.:
11/129740
Inventors:
Pei Jin - Palo Alto CA, US
H. Shepard - San Francisco CA, US
H. Shepard - San Francisco CA, US
International Classification:
A61K 39/395
C07H 21/04
C12P 21/06
C07K 14/705
C07K 16/28
C07H 21/04
C12P 21/06
C07K 14/705
C07K 16/28
US Classification:
424143100, 530350000, 530388220, 435069100, 435320100, 435325000, 536023500
Abstract:
Isoforms of cell surface receptors, including isoforms of receptor tyrosine kinases, and pharmaceutical compositions containing the isoforms are provided. Chimeras of and conjugates containing the cell surface receptors that contain a portion, such as an extracellular domain, from one cell surface receptor, and a second portion, particularly an intron-encoded portion, from a second cell surface protein also are provided. The isoforms modulate the activity of a cell surface receptor. Methods for identifying and preparing isoforms of cell surface receptors including receptor tyrosine kinases are provided. Also provided are methods of treatment with the cell surface receptor isoforms.
Isoforms Of Receptor For Advanced Glycation End Products (Rage) And Methods Of Identifying And Using Same
View pageUS Patent:
20070087406, Apr 19, 2007
Filed:
May 4, 2006
Appl. No.:
11/429090
Inventors:
Pei Jin - Palo Alto CA, US
H. Shepard - San Francisco CA, US
H. Shepard - San Francisco CA, US
International Classification:
A61K 38/17
C07K 14/705
C07H 21/04
C12P 21/06
C07K 14/705
C07H 21/04
C12P 21/06
US Classification:
435069100, 435320100, 435325000, 530350000, 536023500, 514012000
Abstract:
Isoforms of RAGE and pharmaceutical compositions containing RAGE isoforms are provided. Methods for identifying and preparing RAGE isoforms are provided. Also provided are methods of treatment with the RAGE isoforms.
Hepatocyte Growth Factor Intron Fusion Proteins
View pageUS Patent:
20070161081, Jul 12, 2007
Filed:
Oct 31, 2006
Appl. No.:
11/590955
Inventors:
Pei Jin - Palo Alto CA, US
H. Shepard - San Francisco CA, US
Irene Ni - Foster City CA, US
H. Shepard - San Francisco CA, US
Irene Ni - Foster City CA, US
Assignee:
Receptor Biologix, Inc. - South San Francisco CA
International Classification:
A61K 38/18
C07K 14/475
C07H 21/04
C12P 21/06
C07K 14/475
C07H 21/04
C12P 21/06
US Classification:
435069100, 435320100, 435325000, 514012000, 530399000, 536023500
Abstract:
Isoforms of ligands, including isoforms of hepatocyte growth factor (HGF) containing an intron-encoded portion, and pharmaceutical compositions containing HGF isoforms are provided. The HGF ligand isoforms and compositions containing them can be used in methods of treatment of diseases, such as cancer and other angiogenic diseases.